Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Bonafide and Synthpop announce partnership at MedTrade 2024 | ||
By: PR Newswire Association LLC. - 26 Mar 2024 | Back to overview list |
|
DALLAS, March 26, 2024 /PRNewswire/ -- In a groundbreaking move poised to revolutionize the patient intake and resupply processes, Bonafide and Synthpop have announced a strategic partnership. The announcement comes during MedTrade 2024, the year's most anticipated Durable Medical Equipment (DME) conference. "We're excited to make Synthpop's AI agents available to Bonafide customers... to set new industry standards." Bonafide is the #1 ERP software for DME and HME workflow management. Synthpop uses advanced AI solutions to streamline workflows, making it a perfect match to enhance and scale the Bonafide product offering. The healthcare and AI experts at Synthpop are developing a custom solution to power the evolution of Bonafide's software. The result is a system that is touchless, more efficient and accurate, and gets patients the care they need, faster. Synthpop offers AI agents specializing in DME workflows, directly integrated within Bonafide's software solution. Elad Ferber, CEO of Synthpop, shared his vision for the partnership: "Our mission at Synthpop is to use AI to make complex processes touchless - improving speed and accuracy without compromising security. We're excited to make Synthpop's AI agents available to Bonafide customers, and elevate Bonafide's already stellar offering to set new industry standards." Tom Waller, Senior Director of Client Engagement at Bonafide, emphasized the customer-centric focus of the partnership, "At Bonafide, we're constantly seeking ways to not just meet, but exceed our clients' expectations. This partnership with Synthpop is a testament to our commitment to innovation and excellence. By streamlining the patient intake process, we're not just improving our software; we're enhancing the care that patients receive." The announcement of this partnership at MedTrade 2024 underscores both companies' commitment to advancing healthcare technology and improving patient outcomes. Attendees at the conference will have the opportunity to witness firsthand the potential of this collaboration to reshape the future of patient care, at booth 633. About Bonafide About Synthpop For more information, please email marketing@synthpop.ai View original content to download multimedia:https://www.prnewswire.com/news-releases/bonafide-and-synthpop-announce-partnership-at-medtrade-2024-302098872.html SOURCE Synthpop |
||
|
||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |